Completion of enrollment marks significant milestone in progression of heart failure clinical program and included the largest number of participants to date to receive AB-1002 AskBio Inc. (AskBio), a ...

Final participant randomized in the GenePHIT Phase 2 clinical trial assessing safety and efficacy of AB-1002 for adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III ...

Diamyd Medical today announced the completion of a pre-specified interim efficacy analysis on C-peptide in the ongoing pivotal Phase 3 DIAGNODE-3 trial evaluating retogatein (rhGAD65) in individuals ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, announced that the randomization of the last participant was completed earlier this ...

Quantum dot–based time-bin QKD achieves stable, long-distance secure communication with practical performance.

PERRYSBURG, Ohio — Construction is now underway in Perrysburg as phase two of the city’s downtown revitalization project begins, bringing road closures, limited parking, and growing concerns from both ...

Modality-agnostic decoders leverage modality-invariant representations in human subjects' brain activity to predict stimuli irrespective of their modality (image, text, mental imagery).

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...

JPMorgan's stance remains an outlier. Of the 54 analysts covering Tesla, only ten carry an "Underperform" or "Sell" rating. Morgan Stanley's Andrew Percoco maintains a $415 price target, roughly 17 ...

Production to start at 4 ktpa LCE, works to expand production capacity to 5.2 ktpa LCE soon to commence ...